Is TG Therapeutics (NASDAQ:TGTX) Using Too Much Debt?

Simply Wall St55minutes ago

TG Therapeutics to Participate in the Evercore HealthCONx Conference

GlobeNewswireNov 29 08:00 ET

JP Morgan Maintains Overweight on TG Therapeutics, Raises Price Target to $43

BenzingaNov 25 09:22 ET · Ratings

TG Therapeutics Analyst Ratings

BenzingaNov 25 09:22 ET · Ratings

J.P. Morgan Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $43

Moomoo NewsNov 25 07:39 ET · Ratings

Express News | TG Therapeutics Inc : JP Morgan Raises Target Price to $43 From $30

ReutersNov 25 01:07 ET